The University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC) is a National
Cancer Institute-designated cancer center, a distinction that places it in
the top tier of cancer centers throughout the country.
Located on the medical campus of the University of Maryland at Baltimore, UMGCC brings
together expert researchers and clinicians from the University of Maryland School
of Medicine to collaborate on preventing, detecting, and treating cancer. As part of an academic
medical community, UMGCC integrates cutting-edge cancer treatment with leadership
in cancer research and a commitment to medical education.
UMGCC's philosophy and goals are summed up in its mission statement:
The mission of the UMGCC is to undertake innovative basic and clinical research that will impact the understanding and treatment of cancer around the world and to provide state-of-the-art clinical care to cancer patients in Maryland and beyond.
The center's "bench to bedside" approach -- emphasizing the connection between
research and clinical practice -- is embodied in the bridge that connects the
clinical area of the hospital building to UMGCC's laboratories in the University
of Maryland School of Medicine Bressler Research Building. Clinical scientists
working with patients have ready access to research laboratories where they
investigate cancer causes and treatments. The interaction between laboratory
and clinic continues to generate new ideas and methods for the prevention and
treatment of cancer. Constant emphasis is focused on the cancer patient as the
foundation for our activities.
UMGCC's rich tradition of treatment, research, and education,
combined with its continuing commitment to making patients its primary focus,
gives the center its outstanding reputation across Maryland and throughout the United States and the world.
This page was last updated: April 16, 2015